Jennifer Lowery

Accomplished Registered Nurse with experience in clinical research coordination and emergency care at UMMC, including the Clinical Research Support Program and the Adult Emergency Department. Proficiency in clinical trial management, focusing on optimizing participant recruitment and retention strategies. Proven track record of exceptional documentation management and critical thinking skills, ensuring adherence to regulatory standards while delivering superior patient care. Career objectives include further enhancing research education and advancing patient safety protocols.

• RN License, #913240, 12/26
• BLS, 06/26
• ACLS, 06/26
• NIHSS, 04/25
• CEN, 05/25
• USGPIV, 2022
• CITI Training, 2023
• IATA Training, 2023
• CREW Training, 2023

• Member of American Nurse Association
• Member of Emergency Nurse Association

• ATyr Pharma, Inc.: ATYR1923-C-004, A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients with Pulmonary Sarcoidosis (EFZO-FIT)
• Penumbra, Inc.: CLP 11899.B, MIND: A Prospective, Multicenter Study of Artremis, a Minimally Invasive Neuro Evacuation Device, in the Removal of Intracerebral Hemorrhage (MIND)
• Mitsubishi Tanabe Pharma Group: MT-3921-A01, A Phase 2a, Randomized, Double-Blind, Placebo-controlled Study to Assess the Efficacy and Safety of MT-3921 in Subject with Acute Traumatic Cervical Spinal Cord Injury
• National Institutes of Health (NIH): RECOVER-AUTONOMIC, A Platform Protocol for Evaluation of Interventions for Autonomic Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) (Recover AUTO)
• Pfizer: B0661037/CV185-325, A Randomized, Open-Label, Active Controlled, Safety and Descriptive Efficacy Study in Pediatric Subjects Requiring Anticoagulation for the Treatment of Venous Thromboembolic Event (Apixaban)
• Sanofi US Services Inc.: EFC17560, A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab monotherapy by subcutaneous injection in participants aged 12 years and older with moderate-to-severe atopic dermatitis (COAST 2)
• US Endoscopy/STERIS, Cryospray Therapy for Benign Airway Stenosis: a pilot study (pilot-CRYSTASIS)
• Impact of Oral Immulina Supplementation on Natural Killer Cell Activities and Other Biomarkers Associated with Increasing Host Immune Resilience to Upper Respiratory Viruses in Normal Human Volunteers (Immulina Flu)
• University of Alabama at Birmingham: UAB2031, Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients receiving Neoadjuvant Chemotherapy with Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer who are Folate Receptor a positive